Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-25

Reporting Person: Sommadossi Jean-Pierre (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-25	Common Stock	C	52581	—	Acquired	143182	Indirect
2018-06-25	Common Stock	C	35258	—	Acquired	178440	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-25	Series A Convertible Perferred Stock	$	C	52581	Disposed		Common Stock (52581)	Indirect
2018-06-25	Series B Convertible Perferred Stock	$	C	35258	Disposed		Common Stock (35258)	Indirect

Footnotes

F1: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.